NCT03151499View on ClinicalTrials.gov

Drug-drug Interaction Trial Between Rifampicin and BI 409306 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

May 30, 2017

Primary Completion Date

July 11, 2017

Study Completion Date

July 11, 2017

Conditions
Healthy
Interventions
DRUG

BI 409306

Reference and Test Treatment

DRUG

Rifampicin

Test Treatment

Trial Locations (1)

88397

Humanpharmakologisches Zentrum Biberach, Biberach

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY